Abstract |
Anticancer agents act, at least in part, by inducing reactive oxygen and nitrogen species (RONS). We examined the redox effect on SW480 and HT-29 colon cancer cells of four anticancer compounds, arsenic trioxide, phosphoaspirin, phosphosulindac, and nitric oxide-donating aspirin ( NO-ASA). All compounds inhibited the growth of both cell lines (IC(50), 10-90 micromol/L) and induced RONS detected by a general RONS molecular probe. NO-ASA, which induced at least four individual RONS (NO, H(2)O(2), superoxide anion, and peroxynitirte), induced apoptotic and necrotic cell death that was RONS-mediated (cell death paralleled RONS levels and was abrogated by N-acetyl cysteine but not by diphenylene iodonium, which displayed prooxidant activity and enhanced cell death). Nuclear factor-kappaB and mitogen-activated protein kinases were modulated by RONS. Thioredoxin-1 (Trx-1), an oxidoreductase involved in redox regulation, was heavily oxidized in response to RONS and mediated the growth inhibitory effect of the anticancer agents; knocking-down trx-1 expression by small interfering RNA abrogated cell death induced by them. These compounds also inhibited the activity of Trx reductase that reduces oxidized Trx-1, whereas the Trx reductase inhibitor aurothiomalate synergized with NO-ASA in the induction of cell death. Our findings indicate that the Trx system mediates to a large extent redox-induced cell death in response to anticancer agents. This mechanism of action may be shared by more anticancer agents and deserves further assessment as a candidate mechanism for the pharmacologic control of cancer.
|
Authors | Yu Sun, Basil Rigas |
Journal | Cancer research
(Cancer Res)
Vol. 68
Issue 20
Pg. 8269-77
(Oct 15 2008)
ISSN: 1538-7445 [Electronic] United States |
PMID | 18922898
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antineoplastic Agents
- Arsenicals
- NF-kappa B
- Nitric Oxide Donors
- Organophosphates
- Oxides
- Reactive Nitrogen Species
- Reactive Oxygen Species
- phosphoaspirin
- Gold Sodium Thiomalate
- Thioredoxins
- Thioredoxin-Disulfide Reductase
- Mitogen-Activated Protein Kinases
- MAP Kinase Kinase Kinase 5
- MAP3K5 protein, human
- Aspirin
- Arsenic Trioxide
|
Topics |
- Antineoplastic Agents
(pharmacology)
- Apoptosis
(drug effects)
- Arsenic Trioxide
- Arsenicals
(pharmacology)
- Aspirin
(analogs & derivatives, pharmacology)
- Gold Sodium Thiomalate
(pharmacology)
- HT29 Cells
- Humans
- MAP Kinase Kinase Kinase 5
(physiology)
- Mitogen-Activated Protein Kinases
(metabolism)
- NF-kappa B
(metabolism)
- Nitric Oxide Donors
(pharmacology)
- Organophosphates
(pharmacology)
- Oxidation-Reduction
- Oxidative Stress
- Oxides
(pharmacology)
- Reactive Nitrogen Species
(metabolism)
- Reactive Oxygen Species
(metabolism)
- Thioredoxin-Disulfide Reductase
(antagonists & inhibitors)
- Thioredoxins
(physiology)
|